GlassScriptPhysician profile
Jon R Wieringa
NPI 1518977230
$2,460.80
in general payments reported to CMS, 2019-2025
16 companies · $600 in 2025
The $600 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $116 · 2021: $255 · 2022: $366 · 2023: $393 · 2024: $190 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.19 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $828.95 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $657.32 | 2019-2025 | Precision7, Tryptyr, Total30 |
| Novartis Pharmaceuticals Corporation | $184.07 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $175.03 | 2023-2025 | Miebo, Xiidra, Infuse |
| Biotissue Holdings INC. | $155.31 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $102.35 | 2022-2025 | Cequa |
| Kala Pharmaceuticals, INC. | $68.22 | 2021 | |
| Sight Sciences, INC. | $60.34 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.94 | 2019 | |
| Abbvie INC. | $45.85 | 2022-2023 | Lumigan, Vuity |
| Shire North American Group INC | $38.99 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $34.32 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $21.92 | 2022 | |
| Allergan, INC. | $13.74 | 2019 | |
| Alcon Research LLC | $13.09 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $10.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Wieringa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.